Skip to main content
. 2021 Sep 29;11:752545. doi: 10.3389/fonc.2021.752545

Figure 1.

Figure 1

Kaplan-Meier curves of (A) PFS and (B) OS comparing pembrolizumab-pemetrexed-platinum combination and bevacizumab-pemetrexed-platinum combination. CI, confidence interval; HR, hazard ratio; OS, overall survival; PFS, progression-free survival.